Balase, Baby Girl .
HRN: 26-97-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2025
AMPICILLIN 250MG (VIAL)
04/24/2025
04/30/2025
IVTT
200mg
Q12H
MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes